Oncology Clinical Trials Office, University of Oxford

Malignant tumor of pancreas (disorder)

Clinical Trial: SPARC

Year Started: 2015

A phase 1 trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer



Access:
Access restricted at present
Type:
Clinical Trial
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Followup records 0 - 3 months
Imaging data 0 - 3 months
Pathology records 0 - 3 months
Physiological/biochemical measurements 0 - 3 months
Treatment records 0 - 3 months


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Whole blood -60°C to -85°C N/A Not applicable 0 - 10%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Whole blood -60°C to -85°C N/A Not applicable 0 - 10%


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) -60°C to -85°C N/A Not applicable 0 - 10%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Peripheral blood mononuclear cells (PBMC) -60°C to -85°C N/A Not applicable 0 - 10%


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Plasma -60°C to -85°C N/A Not applicable 0 - 10%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Plasma -60°C to -85°C N/A Not applicable 0 - 10%

Malignant tumor of ovary (disorder)

Clinical Trial: OCTOVA

Year Started: 2017

See ClinicalTrials.gov reference NCT03117933 for more information about the study. Whole blood and plasma samples pre and post-treatment with i.PARPi ii. control or iii. PARPi & anti-angiogenic. FFPE diagnostoc tumour sample.



Access:
Access restricted at present
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
There is no associated data for this collection.


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Plasma -60°C to -85°C N/A Not applicable 0 - 10%
Tissue specimen Surgical procedure (procedure) RT N/A Affected 0 - 10%
Whole blood -60°C to -85°C N/A Not applicable 0 - 10%

Malignant tumor of lung (disorder)

Clinical Trial: ARCADIAN

Year Started: 2021

A phase I dose escalation study to investigate combining the antimalarial drug atovaquone with chemoradiotherapy in non-small cell lung cancer, using a time to event continual reassessment method (TiTE CRM).



Access:
Access restricted at present
Type:
Clinical Trial
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Biomarker datasets > 6 months
Followup records > 6 months
Imaging data > 6 months
Physiological/biochemical measurements > 6 months
Treatment records > 6 months


Female

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Plasma -60°C to -85°C Not applicable 75% -99%


Male

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Plasma -60°C to -85°C Not applicable 75% -99%


Female

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen RT Paraffin Not applicable 75% -99%


Male

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen RT Paraffin Not applicable 75% -99%

Malignant tumor of rectum (disorder)

Clinical Trial: CEDAR

Year Started: 2019

A Phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer



Access:
Access restricted at present
Type:
Clinical Trial
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
There is no associated data for this collection.


Female

Young adult (18 - 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Faeces RT Not applicable 0 - 10%
RNA -60°C to -85°C Not applicable 0 - 10%
Tissue specimen RT Paraffin Not applicable 0 - 10%
Whole blood RT Not applicable 0 - 10%


Female

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Faeces RT Not applicable 0 - 10%
RNA -60°C to -85°C Not applicable 0 - 10%
Tissue specimen RT Paraffin Not applicable 0 - 10%
Whole blood RT Not applicable 0 - 10%


Male

Young adult (18 - 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
RNA -60°C to -85°C Not applicable 0 - 10%
Tissue specimen RT Not applicable 0 - 10%
Whole blood RT Not applicable 0 - 10%
Faeces RT Not applicable 0 - 10%


Male

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Faeces RT Not applicable 0 - 10%
RNA -60°C to -85°C Not applicable 0 - 10%
Tissue specimen RT Not applicable 0 - 10%
Whole blood RT Not applicable 0 - 10%